What is the recommended dosage of Macrobid (nitrofurantoin monohydrate) for treating uncomplicated urinary tract infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Macrobid (Nitrofurantoin Monohydrate) for Uncomplicated UTIs

The recommended dosage of Macrobid (nitrofurantoin monohydrate/macrocrystals) for treating uncomplicated urinary tract infections is 100 mg twice daily for 5 days. 1

Evidence-Based Recommendation

  • Nitrofurantoin monohydrate/macrocrystals (100 mg twice daily for 5 days) is considered a first-line therapy for uncomplicated UTIs due to its minimal resistance patterns and limited propensity for collateral damage 1
  • Clinical trials demonstrate that this 5-day regimen provides efficacy comparable to 3 days of trimethoprim-sulfamethoxazole 1
  • The 5-day regimen has been shown to achieve clinical cure rates of 90% and bacterial cure rates of 92% in controlled studies 1

Clinical Efficacy

  • Studies demonstrate a clinical cure rate with nitrofurantoin of 88%-93% and a bacterial cure rate of 81%-92% 1
  • In direct comparisons, nitrofurantoin monohydrate/macrocrystals (100 mg twice daily) has shown similar clinical cure rates to:
    • Ciprofloxacin (93% vs 95%) 1
    • Trimethoprim-sulfamethoxazole (93% vs 95%) 1
    • Fosfomycin trometamol single dose (95% vs 90%) 1

Treatment Duration Considerations

  • While some international guidelines may recommend shorter courses, the 5-day regimen has the strongest evidence base for nitrofurantoin specifically 2
  • A randomized controlled trial by Gupta et al. (2007) demonstrated that a 5-day course of nitrofurantoin is equivalent clinically and microbiologically to a 3-day course of trimethoprim-sulfamethoxazole 3
  • The 2024 European Association of Urology guidelines also recommend 5 days as the standard duration for nitrofurantoin monohydrate/macrocrystals at 100 mg twice daily 1

Important Clinical Considerations

  • Nitrofurantoin is contraindicated in patients with renal impairment of any degree 4
  • It should not be used in the last three months of pregnancy 4
  • Common side effects include nausea and headache 1
  • Serious adverse effects like pulmonary reactions and polyneuropathy are primarily associated with long-term use, not short-course therapy 4
  • Nitrofurantoin has maintained good activity against common uropathogens including Escherichia coli, Staphylococcus saprophyticus, and Enterococcus species despite decades of use 4

Alternative Formulations

  • Other nitrofurantoin formulations have different dosing regimens:
    • Nitrofurantoin macrocrystals: 50-100 mg four times daily for 5 days 1
    • Nitrofurantoin macrocrystals prolonged release: 100 mg twice daily for 5 days 1

Follow-up Recommendations

  • Routine post-treatment urinalysis or urine cultures are not indicated for asymptomatic patients 1
  • For women whose symptoms do not resolve by the end of treatment or recur within 2 weeks, a urine culture with antimicrobial susceptibility testing should be performed 1

In conclusion, the 5-day regimen of nitrofurantoin monohydrate/macrocrystals (100 mg twice daily) represents the optimal balance of efficacy, safety, and resistance prevention for uncomplicated UTIs, as supported by multiple high-quality clinical trials and international guidelines.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nitrofurantoin: what is the evidence for current UK guidance?

The Journal of antimicrobial chemotherapy, 2023

Research

[Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].

Medizinische Monatsschrift fur Pharmazeuten, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.